Seite - 100 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Pearsonetal. Nanoparticlebiomoleculecorona Hubbell, J.A.,andLanger,R.(2013).Translatingmaterialsdesigntotheclinic.Nat. Mater.12,963–966.doi:10.1038/nmat3788 Karlsson, M., Mårtensson, L.-G., Jonsson, B.-H., and Carlsson, U. (2000). Adsorption of human carbonic anhydrase II variants to silica nanoparticles occur stepwise: binding is followedby successive conformational changes to a molten-globule-like state.Langmuir16,8470–8479.doi:10.1021/la0002738 Karmali, P. P., and Simberg,D. (2011). Interactions of nanoparticleswith plasma proteins: implicationonclearanceand toxicityofdrugdelivery systems.Expert Opin.DrugDeliv.8,343–357.doi:10.1517/17425247.2011.554818 Lindman, S., Lynch, I., Thulin, E., Nilsson, H., Dawson, K. A., and Linse, S. (2007). Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effectsofparticle sizeandhydrophobicity.NanoLett.7,914–920.doi:10.1021/ nl062743+ Linse, S., Cabaleiro-Lago,C., Xue,W. F., Lynch, I., Lindman, S., Thulin, E., et al. (2007).Nucleationofproteinfibrillationbynanoparticles.Proc.Natl.Acad.Sci. U.S.A.104,8691–8696.doi:10.1073/pnas.0701250104 Lundqvist,M.,Stigler,J.,Elia,G.,Lynch,I.,Cedervall,T.,andDawson,K.A.(2008). Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.Proc. Natl. Acad. Sci. U.S.A. 105, 14265–14270.doi:10.1073/pnas.0805135105 Lynch, I.,Dawson,K.A., andLinse, S. (2006).Detecting cryptic epitopes created bynanoparticles.Sci.STKE2006:pe14.doi:10.1126/stke.3272006pe14 Martin, S.,Manuela, S.-B.,Hakan, S., Shinji, T., Alexander,W., Carsten, S., et al. (2013). Serumprotein identification andquantificationof the corona of 5, 15 and 80nmgold nanoparticles.Nanotechnology 24:265103. doi: 10.1088/0957- 4484/24/26/265103 Milani, S., Baldelli Bombelli, F., Pitek,A. S.,Dawson,K.A., andRädler, J. (2012). Reversible versus irreversible binding of transferrin to polystyrene nanoparti- cles: softandhardcorona.ACSNano6,2532–2541.doi:10.1021/nn204951s Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J., and Kraft, M. L. (2013). Proteincorona significantly reduces active targetingyield.Chem.Commun.49, 2557–2559.doi:10.1039/c3cc37307j Monopoli,M., Pitek,A., Lynch, I., andDawson,K. (2013). “Formationandchar- acterizationof thenanoparticle–protein corona,” inNanomaterial Interfaces in Biology, edsP.BergeseandK.Hamad-Schifferli (NewYork,NY:HumanaPress), 137–155.doi:10.1007/978-1-62703-462-3_11 Monopoli,M. P., Aberg, C., Salvati, A., andDawson, K. A. (2012). Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol.7,779–786.doi:10.1038/nnano.2012.207 Mortensen,N. P.,Hurst, G. B.,Wang,W., Foster, C.M.,Nallathamby, P.D., and Retterer, S. T. (2013). Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity.Nanoscale 5, 6372–6380. doi: 10.1039/c3nr33280b Mortimer,G.M., Butcher,N. J.,Musumeci, A.W.,Deng, Z. J.,Martin,D. J., and Minchin, R. F. (2014). Cryptic epitopes of albumin determinemononuclear phagocyte system clearance of nanomaterials. ACS Nano 8, 3357–3366. doi: 10.1021/nn405830g Nel, A. E., Madler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., et al. (2009). Understanding biophysicochemical interactions at the nano-bio interface.Nat.Mater.8,543–557.doi:10.1038/nmat2442 Owens, D. E. III., and Peppas, N. A. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93–102. doi: 10.1016/j.ijpharm.2005.10.010 Paula, A. J., Araujo Junior, R. T.,Martinez, D. S., Paredes-Gamero, E. J., Nader, H. B., Duran, N., et al. (2013). Influence of protein corona on the transport ofmolecules into cells bymesoporous silica nanoparticles.ACS Appl. Mater. Interfaces5,8387–8393.doi:10.1021/am4014693 Pearson,R.M.,Hsu,H.-J.,Bugno,J.,andHong,S.(2014).Understandingnano-bio interactions to improvenanocarriers fordrugdelivery.MRSBull.39, 227–237. doi:10.1557/mrs.2014.9 Pearson,R.M.,Sunoqrot,S.,Hsu,H.-J.,Bae, J.W.,andHong,S. (2012).Dendritic nanoparticles: thenextgenerationofnanocarriers?Ther.Deliv.3,941–959.doi: 10.4155/tde.12.76 Peer,D.,Karp,J.M.,Hong,S.,Farokhzad,O.C.,Margalit,R.,andLanger,R.(2007). Nanocarriers as an emergingplatform for cancer therapy.Nat.Nanotechnol.2, 751–760.doi:10.1038/nnano.2007.387 Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X.-Q., Jiang, L., et al. (2013). Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34, 8521–8530. doi:10.1016/j.biomaterials.2013.07.102 Perry, J. L., Reuter, K.G., Kai,M. P.,Herlihy, K. P., Jones, S.W., Luft, J. C., et al. (2012).PEGylatedPRINTnanoparticles: the impactofPEGdensityonprotein binding,macrophageassociation,biodistribution,andpharmacokinetics.Nano Lett.12,5304–5310.doi:10.1021/nl302638g Romberg, B., Hennink, W. E., and Storm, G. (2008). Sheddable coatings for long-circulatingnanoparticles.Pharm.Res.25,55–71.doi:10.1007/s11095-007- 9348-7 Sacchetti, C., Motamedchaboki, K., Magrini, A., Palmieri, G., Mattei, M., Bernardini, S., et al. (2013). Surface polyethylene glycol conformation influ- ences theprotein coronaofpolyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 7, 1974–1989.doi:10.1021/nn400409h Sakulkhu,U.,Mahmoudi,M.,Maurizi,L.,Salaklang, J., andHofmann,H.(2014a). Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci. Rep. 4:5020. doi: 10.1038/srep05020 Sakulkhu,U.,Maurizi, L.,Mahmoudi,M.,Motazacker,M., Vries,M., Gramoun, A., et al. (2014b). Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats.Nanoscale 6, 11439–11450.doi:10.1039/C4NR02793K Salvati, A., Pitek, A. S.,Monopoli,M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., et al. (2013). Transferrin-functionalized nanoparticles lose their tar- geting capabilities when a biomolecule corona adsorbs on the surface.Nat. Nanotechnol.8,137–143.doi:10.1038/nnano.2012.237 Saptarshi, S.R.,Duschl,A., andLopata,A.L. (2013). Interactionofnanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J.Nanobiotechnol. 11:26.doi:10.1186/1477-3155-11-26 Shang,L.,Wang,Y., Jiang, J., andDong, S. (2007). pH-dependentprotein confor- mational changes in albumin:goldnanoparticle bioconjugates: a spectroscopic study.Langmuir23,2714–2721.doi:10.1021/la062064e Shannahan, J.H., Lai,X.,Ke, P.C., Podila, R., Brown, J.M., andWitzmann, F.A. (2013). Silver nanoparticle protein corona composition in cell culturemedia. PLoSONE8:e74001.doi:10.1371/journal.pone.0074001 Sunoqrot, S., Bugno, J., Lantvit, D., Burdette, J. E., and Hong, S. (2014). Prolonged blood circulation nd enhanced tumor accumulation of folate- targeted dendrimer-polymer hybrid nanoparticles. J. Control. Release 191, 115–122.doi:10.1016/j.jconrel.2014.05.006 Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., et al. (2013).Rapidformationofplasmaproteincoronacriticallyaffectsnanoparticle pathophysiology.Nat.Nanotechnol.8,772–781.doi:10.1038/nnano.2013.181 van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., and van Gaal, E. V. B. (2013). Ligand-targeted particulate nanomedicines undergoing clin- ical evaluation: current status. Adv. Drug Deliv. Rev. 65, 1284–1298. doi: 10.1016/j.addr.2013.08.012 Vroman, L., Adams, A. L., Fischer, G. C., andMunoz, P. C. (1980). Interaction of highmolecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces.Blood55,156–159. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., and Chan, W. C. W. (2011). Nanoparticle size and surface chemistry determine serum protein adsorp- tion and macrophage uptake. J. Am. Chem. Soc. 134, 2139–2147. doi: 10.1021/ja2084338 Walkey, C.D.,Olsen, J. B., Song, F., Liu, R., Guo,H.,Olsen,D.W., et al. (2014). Proteincoronafingerprintingpredicts thecellular interactionofgoldandsilver nanoparticles.ACSNano8,2439–2455.doi:10.1021/nn406018q Wolfram, J., Suri, K., Yang, Y., Shen, J., Celia, C., Fresta, M., et al. (2014b). Shrinkage of pegylated and non-pegylated liposomes in serum.Colloids Surf. BBiointerfaces114,294–300.doi:10.1016/j.colsurfb.2013.10.009 Wolfram, J., Yang, Y., Shen, J., Moten, A., Chen, C., Shen, H., et al. (2014a). The nano-plasma interface: implications of the protein corona.Colloids Surf. BBiointerfaces.doi:10.1016/j.colsurfb.2014.02.035. [Epubaheadofprint]. Yan, Y., Gause, K. T., Kamphuis,M.M. J., Ang, C.-S., O’Brien-Simpson, N.M., Lenzo, J. C., et al. (2013).Differential roles of the protein corona in the cellu- laruptakeofnanoporouspolymerparticles bymonocyte andmacrophage cell lines.ACSNano7,10960–10970.doi:10.1021/nn404481f Zhang,L.,Gu,F.X.,Chan, J.M.,Wang,A.Z., Langer,R. S., andFarokhzad,O.C. (2008).Nanoparticles inmedicine: therapeuticapplicationsanddevelopments. Clin.Pharmacol.Ther.83,761–769.doi:10.1038/sj.clpt.6100400 Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article108 | 100